Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | CAPSULE;ORAL | 1MG | 0 | POMALIDOMIDE | POMALIDOMIDE |
002 | CAPSULE;ORAL | 2MG | 0 | POMALIDOMIDE | POMALIDOMIDE |
003 | CAPSULE;ORAL | 3MG | 0 | POMALIDOMIDE | POMALIDOMIDE |
004 | CAPSULE;ORAL | 4MG | 0 | POMALIDOMIDE | POMALIDOMIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-10-30 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2021-05-28 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2021-05-28 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 2 | Null | 7 |
SUPPL | 3 | Null | 7 |
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
004 | Prescription | AB |
CDER Filings
EUGIA PHARMA
cder:Array
(
[0] => Array
(
[ApplNo] => 210249
[companyName] => EUGIA PHARMA
[docInserts] => ["",""]
[products] => [{"drugName":"POMALIDOMIDE","activeIngredients":"POMALIDOMIDE","strength":"1MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"POMALIDOMIDE","activeIngredients":"POMALIDOMIDE","strength":"2MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"POMALIDOMIDE","activeIngredients":"POMALIDOMIDE","strength":"3MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"POMALIDOMIDE","activeIngredients":"POMALIDOMIDE","strength":"4MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/30\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/210249Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-10-30
)
)